CYP 1.82% 27.0¢ cynata therapeutics limited

Ann: CYP Advances Towards Osteoarthritis Phase 2 Clinical Trial, page-51

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,172 Posts.
    lightbulb Created with Sketch. 1439
    With our Phase 2 trial on Osteoarthritis starting in Quarter 1 2020.

    http://files.cynata.com/517/19.10.03.CYP-Advances-Towards-Osteoarthritis-Phase-2-Clinical-Trial.pdf

    Maybe it might pay our board to get in-contact with Doctor Kade Paterson, from University of Melbourne.

    Foot pain pressure, Researchers now know arthritis of the foot is a common condition and are carrying out clinical trials to help keep Australians mobile and on their feet.

    https://www.9news.com.au/videos/national/foot-pain-pressure/ck43w8mjw003i0hrz96wlw1uw

    It would not hurt C.Y.P. if they can some how, help them in this trial.

    Regards

    Rossi70
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
(20min delay)
Last
27.0¢
Change
-0.005(1.82%)
Mkt cap ! $48.78M
Open High Low Value Volume
27.5¢ 28.5¢ 26.5¢ $71.17K 257.3K

Buyers (Bids)

No. Vol. Price($)
4 145786 27.0¢
 

Sellers (Offers)

Price($) Vol. No.
28.0¢ 15000 1
View Market Depth
Last trade - 16.10pm 04/10/2024 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.